LIMITATIONS OF BUSULFAN/FLUDARABINE-BASED PREPARATIVE REGIMEN IN CTLA-4 HAPLOINSUFFICIENCY TO ACHIEVING DISEASE PHENOTYPE CORRECTION

被引:0
|
作者
Parker, Loretta [1 ]
Kapadia, Malika [2 ]
Chellapandian, Deepak [3 ]
Whangbo, Jennifer [2 ]
Grace, Rachael [2 ]
Prince, Chengyu [1 ]
Parikh, Suhag
Bray, Robert [4 ]
Gebel, Howard [4 ]
Chandrakasan, Shanmuganathan [1 ]
机构
[1] Childrens Healthcare Atlanta Emory Univ, Atlanta, GA USA
[2] Harvard Univ, Boston Childrens Hosp, Dana Farber Canc Inst, Boston, MA 02115 USA
[3] Johns Hopkins All Childrens Hosp, St Petersburg, FL USA
[4] Emory Univ, Atlanta, GA 30322 USA
关键词
D O I
暂无
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
O059
引用
收藏
页码:60 / 60
页数:1
相关论文
共 2 条
  • [1] Limitations of Bu/Flu-based preparative regimen in CTLA-4 haploinsufficiency to achieving disease phenotype correction
    Parker, Loretta
    Kapadia, Malika
    Chellapandian, Deepak
    Whangbo, Jennifer
    Grace, Rachael
    Prince, Chengyu
    Parikh, Suhag
    Bray, Robert
    Gebel, Howard
    Chandrakasan, Shanmuganathan
    CLINICAL IMMUNOLOGY, 2023, 250 : 16 - 17
  • [2] Paediatric high-risk AML: excellent early disease-free-survival using a fludarabine-based myeloablative preparative regimen
    Tan, P. -L.
    Yeoh, A.
    Quah, T. -C.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S100 - S100